Literature DB >> 428108

Uric acid: a risk factor for coronary heart disease?

V W Persky, A R Dyer, E Idris-Soven, J Stamler, R B Shekelle, J A Schoenberger, D M Berkson, H A Lindberg.   

Abstract

The association between serum uric acid and the prevalence of ECG abnormalities was analyzed for 24.997 employed men and women, white and black, age 18--64 years, from the Chicago Heart Association (CHA) Detection Project in Industry. In addition, the relationships between uric acid and 5-year mortality from all causes, from cardiovascular diseases (CVD), and from coronary heart disease (CHD) were analyzed for 7804 white men and women age 45--64 years from this study and 967 white men age 44--63 years from the Chicago People's Gas Company Study. For men, the association between uric acid and the prevalence of ECG abnormalities and with mortality appear to be secondary to associations between uric acid and other risk factors. For women, however, the associations could not be explained by other risk factors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428108     DOI: 10.1161/01.cir.59.5.969

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Recent advances in the epidemiology of gout.

Authors:  Kenneth G Saag; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

4.  Serum urate and the risk of major coronary heart disease events.

Authors:  S G Wannamethee; A G Shaper; P H Whincup
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 5.  Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.

Authors:  J C Adkins; D Faulds
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  Elevated serum uric acid--a facet of hyperinsulinaemia.

Authors:  M Modan; H Halkin; A Karasik; A Lusky
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 7.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

8.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 9.  Gout.

Authors:  J T Scott
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

10.  The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men.

Authors:  Young Seoub Hong; Myeong Jin Lee; Kyeong Hee Kim; Sang Hwa Lee; Yong Hwan Lee; Byoung Gwon Kim; Baekgeun Jeong; Hyeong Ryeol Yoon; Hisahide Nishio; Joon Youn Kim
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.